deferiprone has been researched along with ferrous sulfate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hider, RC; Lamb, DJ; Leake, DS | 1 |
| Bentur, Y; Fernandes, D; Klein, J; Koren, G; Matsui, D; Olivieri, N; Stobie, S; Tyberg, J | 1 |
| Barr, J; Berkovitch, M; Eshel, G; Kariv, N; Schejter, A; Tavori, I | 1 |
| Anderson, D; Chua-Anusorn, W; Cole, C; Vives-Bauza, C; Webb, J; Yardley-Jones, A | 1 |
| Qiao, C; Wang, L; Xiao, SH; Xue, J | 1 |
| Boyd, P; Hyde, DR | 1 |
6 other study(ies) available for deferiprone and ferrous sulfate
| Article | Year |
|---|---|
Hydroxypyridinones and desferrioxamine inhibit macrophage-mediated LDL oxidation by iron but not by copper.
Topics: Animals; Copper; Copper Sulfate; Deferiprone; Deferoxamine; Ferrous Compounds; Humans; In Vitro Techniques; Iron Chelating Agents; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Pyridones | 1993 |
Comparison of the pharmacokinetics of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in healthy volunteers, with and without co-administration of ferrous sulfate, to thalassemia patients.
Topics: Adolescent; Adult; Child; Deferiprone; Ferrous Compounds; Humans; Iron Chelating Agents; Male; Pyridones; Thalassemia | 1993 |
Acute iron intoxication: the efficacy of deferiprone and sodium biocarbonate in the prevention of iron absorption from the digestive tract.
Topics: Animals; Deferiprone; Drug Interactions; Feces; Female; Ferrous Compounds; Intestinal Absorption; Iron; Iron Chelating Agents; Pyridones; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.
Topics: Australia; beta-Thalassemia; Blood Transfusion; Chelating Agents; Chlorides; Comet Assay; Deferiprone; Deferoxamine; DNA Damage; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemosiderin; Humans; Lymphocytes; Male; Pyridones; Reference Values; Spleen | 2000 |
Mefloquine in combination with hemin causes severe damage to adult Schistosoma japonicum in vitro.
Topics: 2,2'-Dipyridyl; Animals; Anthelmintics; Ascorbic Acid; Cysteine; Deferiprone; Deferoxamine; Drug Synergism; Drug Therapy, Combination; Ferric Compounds; Ferrous Compounds; Glutathione; Hemin; Inhibitory Concentration 50; Iron Chelating Agents; Mefloquine; Protoporphyrins; Pyridones; Schistosoma japonicum | 2014 |
Iron contributes to photoreceptor degeneration and Müller glia proliferation in the zebrafish light-treated retina.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Cell Proliferation; Deferiprone; Ependymoglial Cells; Ferrous Compounds; In Situ Nick-End Labeling; Intravitreal Injections; Light; Phospholipid Hydroperoxide Glutathione Peroxidase; Photoreceptor Cells; Radiation Injuries, Experimental; Receptors, Transferrin; Retinal Degeneration; Zebrafish; Zebrafish Proteins | 2022 |